학술논문
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
Document Type
Article
Author
Luke, J.J.; Patel, M.R.; Blumenschein, G.R.; Hamilton, E.; Chmielowski, B.; Ulahannan, S.V.; Asch, A.S.; Connolly, R.M.; Santa-Maria, C.A.; Wang, J.; Bahadur, S.W.; Weickhardt, A.; Mallesara, G.; Clingan, P.; Dlugosz-Danecka, M.; Tomaszewska-Kiecana, M.; Pylypenko, H.; Hamad, N.; Kindler, H.L.; Sumrow, B.J.; Li, H.; Sun, J.; Kaminker, P.; Zhang, X.; Shah, K.; Moore, P.A.; Chen, F.Z.; Smith, D.H.; De Costa, A.; Li, J.
Source
In: Nature Medicine . (Nature Medicine, November 2023, 29(11):2814-2824)
Subject
Language
English
ISSN
1546170X
10788956
10788956